Skip to main content
SpringerLink
Log in

Shigella Sonnei Vaccine

  • Section 2: Prophylactic Anti-Infective Vaccines
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cohen D, Ashkenazi S, Green M, et al. Safety and immunogenicity of investigational shigella conjugate vaccines in Israeli volunteers. Infect Immun 1996 Oct; 64: 4074–7

    PubMed  CAS  Google Scholar 

  2. Ashkenazi S, Passwell JH, Harlev E, et al. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. J Infect Dis 1999 Jun; 179: 1565–8

    Article  PubMed  CAS  Google Scholar 

  3. Cohen D, Ashkenazi S, Green M, et al. Safety, immunogenicity and efficacy of a Shigella sonnei O-specific polysaccharide conjugate vaccine in Israeli volunteers. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995 Sep 17–20; San Francisco, 159

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shigella Sonnei Vaccine. Drugs R&D 2, 222–223 (1999). https://doi.org/10.2165/00126839-199902030-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00019

Keywords

Search

Navigation